143 related articles for article (PubMed ID: 19751733)
1. Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice.
Li X; Ge H; Weiszmann J; Hecht R; Li YS; Véniant MM; Xu J; Wu X; Lindberg R; Li Y
FEBS Lett; 2009 Oct; 583(19):3230-4. PubMed ID: 19751733
[TBL] [Abstract][Full Text] [Related]
2. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
[TBL] [Abstract][Full Text] [Related]
3. Salicylate blocks lipolytic actions of tumor necrosis factor-alpha in primary rat adipocytes.
Zu L; Jiang H; He J; Xu C; Pu S; Liu M; Xu G
Mol Pharmacol; 2008 Jan; 73(1):215-23. PubMed ID: 17911533
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptides, including neuropeptide Y and melanocortins, mediate lipolysis in murine adipocytes.
Bradley RL; Mansfield JP; Maratos-Flier E
Obes Res; 2005 Apr; 13(4):653-61. PubMed ID: 15897473
[TBL] [Abstract][Full Text] [Related]
5. FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity.
Arner P; Pettersson A; Mitchell PJ; Dunbar JD; Kharitonenkov A; Rydén M
FEBS Lett; 2008 May; 582(12):1725-30. PubMed ID: 18460341
[TBL] [Abstract][Full Text] [Related]
6. Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro.
Petersen EW; Carey AL; Sacchetti M; Steinberg GR; Macaulay SL; Febbraio MA; Pedersen BK
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E155-62. PubMed ID: 15383370
[TBL] [Abstract][Full Text] [Related]
7. Different roles of N- and C- termini in the functional activity of FGF21.
Micanovic R; Raches DW; Dunbar JD; Driver DA; Bina HA; Dickinson CD; Kharitonenkov A
J Cell Physiol; 2009 May; 219(2):227-34. PubMed ID: 19117008
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver.
Hotta Y; Nakamura H; Konishi M; Murata Y; Takagi H; Matsumura S; Inoue K; Fushiki T; Itoh N
Endocrinology; 2009 Oct; 150(10):4625-33. PubMed ID: 19589869
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of green tea catechin on the lipid accumulation in 3T3-L1 adipocytes.
Lee MS; Kim CT; Kim IH; Kim Y
Phytother Res; 2009 Aug; 23(8):1088-91. PubMed ID: 19107849
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes.
Chen W; Hoo RL; Konishi M; Itoh N; Lee PC; Ye HY; Lam KS; Xu A
J Biol Chem; 2011 Oct; 286(40):34559-66. PubMed ID: 21849508
[TBL] [Abstract][Full Text] [Related]
11. [Expression and pharmacological evaluation of fusion protein FGF21-L-Fc].
Yao WB; Ren GP; Han Y; Cao HW; Gao HM; Kan FM; Wang Q; Li DS
Yao Xue Xue Bao; 2011 Jul; 46(7):787-92. PubMed ID: 22010347
[TBL] [Abstract][Full Text] [Related]
12. Cell death-inducing DFF45-like effector C is reduced by caloric restriction and regulates adipocyte lipid metabolism.
Magnusson B; Gummesson A; Glad CA; Goedecke JH; Jernås M; Lystig TC; Carlsson B; Fagerberg B; Carlsson LM; Svensson PA
Metabolism; 2008 Sep; 57(9):1307-13. PubMed ID: 18702959
[TBL] [Abstract][Full Text] [Related]
13. Antilipolytic activity of a novel partial A1 adenosine receptor agonist devoid of cardiovascular effects: comparison with nicotinic acid.
Dhalla AK; Santikul M; Smith M; Wong MY; Shryock JC; Belardinelli L
J Pharmacol Exp Ther; 2007 Apr; 321(1):327-33. PubMed ID: 17204748
[TBL] [Abstract][Full Text] [Related]
14. Plasma FGF21 displays a circadian rhythm during a 72-h fast in healthy female volunteers.
Andersen B; Beck-Nielsen H; Højlund K
Clin Endocrinol (Oxf); 2011 Oct; 75(4):514-9. PubMed ID: 21521350
[TBL] [Abstract][Full Text] [Related]
15. FGF21 is increased by inflammatory stimuli and protects leptin-deficient ob/ob mice from the toxicity of sepsis.
Feingold KR; Grunfeld C; Heuer JG; Gupta A; Cramer M; Zhang T; Shigenaga JK; Patzek SM; Chan ZW; Moser A; Bina H; Kharitonenkov A
Endocrinology; 2012 Jun; 153(6):2689-700. PubMed ID: 22474187
[TBL] [Abstract][Full Text] [Related]
16. Administration of myostatin does not alter fat mass in adult mice.
Stolz LE; Li D; Qadri A; Jalenak M; Klaman LD; Tobin JF
Diabetes Obes Metab; 2008 Feb; 10(2):135-42. PubMed ID: 18190427
[TBL] [Abstract][Full Text] [Related]
17. Anti-lipase and lipolytic activities of ursolic acid isolated from the roots of Actinidia arguta.
Kim J; Jang DS; Kim H; Kim JS
Arch Pharm Res; 2009 Jul; 32(7):983-7. PubMed ID: 19641878
[TBL] [Abstract][Full Text] [Related]
18. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids.
Ge H; Li X; Weiszmann J; Wang P; Baribault H; Chen JL; Tian H; Li Y
Endocrinology; 2008 Sep; 149(9):4519-26. PubMed ID: 18499755
[TBL] [Abstract][Full Text] [Related]
19. Coordinated regulation of esterification and lipolysis by palmitate, H2O2 and the anti-diabetic sulfonylurea drug, glimepiride, in rat adipocytes.
Müller G; Wied S; Straub J; Jung C
Eur J Pharmacol; 2008 Nov; 597(1-3):6-18. PubMed ID: 18789917
[TBL] [Abstract][Full Text] [Related]
20. Lipolytic effect of a polyphenolic citrus dry extract of red orange, grapefruit, orange (SINETROL) in human body fat adipocytes. Mechanism of action by inhibition of cAMP-phosphodiesterase (PDE).
Dallas C; Gerbi A; Tenca G; Juchaux F; Bernard FX
Phytomedicine; 2008 Oct; 15(10):783-92. PubMed ID: 18617377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
